U.S. Markets close in 2 hrs 51 mins

Prima Biomed Ltd. (PBMD)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
1.74-0.05 (-2.79%)
As of 12:41PM EDT. Market open.
People also watch
Full screen
Previous Close1.79
Bid1.74 x 100
Ask1.75 x 500
Day's Range1.72 - 1.77
52 Week Range1.70 - 3.26
Avg. Volume55,123
Market Cap42.13M
PE Ratio (TTM)-5.80
EPS (TTM)-0.3
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.26
Trade prices are not sourced from all markets
  • GlobeNewswire7 days ago

    Financial Update 2H17

    SYDNEY, Australia, July 17, 2017-- Prima BioMed Ltd would like to update shareholders on its current financial status subsequent to the closing of the recent U.S. capital raise and yesterday’ s announcement ...

  • GlobeNewswire8 days ago

    Prima BioMed Announces Second Milestone Payment for IMP701 Program

    SYDNEY, Australia, July 16, 2017-- Prima BioMed Ltd today announced it will receive a second undisclosed significant clinical milestone payment from Novartis, based on the collaboration and licensing agreement ...

  • Prima Biomed's Intra-Tumor Study on Lead Candidate Approved
    Zacks14 days ago

    Prima Biomed's Intra-Tumor Study on Lead Candidate Approved

    Prima Biomed Ltd. (PBMD) announced that a new clinical study, INSIGHT, on its lead candidate IMP321 has received regulatory approval for initiation